Evidence map›Paper›PMID 32399864›Full record

SynthesisJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2021

Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials.

Jakrin Kewcharoen, Wasawat Vutthikraivit, Pattara Rattanawong, Narut Prasitlumkum, Nazem W Akoum, T Jared Bunch, Leenhapong Navaravong

Abstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pulmonary vein isolation plus adjunctive therapy for the treatment of atrial fibrillation: a systematic review and meta-analysis.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2024
    Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Jakrin KewcharoenUniversity of Hawaii Internal Medicine Residency Program, 1356 Lusitana St, 7th floor, Honolulu, HI, 96813, USA. jakrin@hawaii.edu.
Wasawat VutthikraivitDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Pattara RattanawongDepartment of Cardiology, Mayo Clinic, Scottsdale, AZ, USA.
Narut PrasitlumkumUniversity of Hawaii Internal Medicine Residency Program, 1356 Lusitana St, 7th floor, Honolulu, HI, 96813, USA.
Nazem W AkoumDivision of Cardiovascular Medicine, University of Washington School of Medicine, Seattle, WA, USA.
T Jared BunchDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Leenhapong NavaravongDivision of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
University of Hawaii System · USUniversity of Utah · USMayo Clinic in Arizona · USTexas Tech University Health Sciences Center · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background/purposeAtrial fibrillation (AF) is the most common arrhythmia worldwide. The sympathetic nervous system plays an important role in initiation and maintenance of AF. Recent studies have shown that renal sympathetic denervation (RSD) reduced AF recurrences after conventional pulmonary vein isolation (PVI). Studies that have evaluated the role of RSD as an adjuvant to PVI have included different patient populations, ablation strategies, and follow-up approaches. We performed a meta-analysis to assess the potential incremental impact of RSD to PVI.

methodsWe searched the databases of MEDLINE and EMBASE from inception to January 2020. Included studies were randomized controlled trials (RCTs) that compared the recurrence rates of AF in patients who underwent PVI and RSD versus PVI alone. Data from each study were combined using the random effects model to calculate odds ratios (OR) and 95% confidence intervals (CIs).

resultsThree RCTs consisted of four different studies during 2014-2020 involving 451 AF patients (223 patients underwent PVI alone and 228 patients underwent PVI with RSD) were included in the meta-analysis. Compared with PVI alone, the PVI with RSD group had a significantly lower risk of AF recurrence (pooled OR = 0.63, 95%CI 0.50-0.80, p < 0.001, I

conclusionsOur systematic review and meta-analysis demonstrated a significant reduction of AF recurrence in select hypertensive patients who underwent RSD in addition to PVI compared with PVI alone. Larger studies are needed to validate the benefits of this approach in other AF populations and across different ablation strategies.

Indexed as

Atrial FibrillationCatheter AblationPulmonary VeinsHumansRandomized Controlled Trials as TopicRecurrenceSympathectomyTreatment OutcomeAtrial fibrillationHypertensionPulmonary vein isolationRenal sympathetic denervation

Identifiers

PMID32399864
OpenAlexW3024745879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.